IL-18R β Antibodies

Santa Cruz Biotechnology features a diverse variety of IL-18R β monoclonal antibodies for research focused on understanding this critical receptor. IL-18R β monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). IL-18R β is a key component of the interleukin-18 receptor complex, which plays a significant role in the immune response by mediating the effects of interleukin-18, a cytokine involved in the activation of T cells and natural killer cells. The receptor is crucial for the regulation of inflammatory responses and has been implicated in various diseases, including autoimmune disorders and cancer. Understanding IL-18R β function is essential for developing targeted therapies and advancing knowledge of immune system dynamics. Researchers can explore IL-18R β expression patterns across different cell types and tissues to uncover new insights about its biological significance. The study of IL-18R β signaling pathways can reveal important mechanisms in immune regulation and disease progression. Investigating IL-18R β interactions with other molecules can lead to discoveries about immune system modulation. Santa Cruz Biotechnology monoclonal antibodies for IL-18R β research support scientists worldwide in advancing our understanding of immune system function and disease mechanisms.